CCL11 and Cognitive impairment: Of interest, human patients with long-COVID and associated cognitive impairment (i.e., “brain fog”) following a mild respiratory SARS-CoV-2 infection had similar elevated CCL11 plasma levels compared to patients without cognitive impairment (127).